DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Vincamine
Vincamine
The National Drugs List
Pharmaceutical Appendix to the Tariff Schedule 2
Systematic Evidence Review from the Blood Pressure Expert Panel, 2013
Study Protocol and Statistical Analysis Plan
Known Bioactive Library: Microsource 1 - US Drug Collection
BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
Page 1 S C Routine Toxicology Library Drug 3,4
Review of Existing Classification Efforts
WHO-EMP-RHT-TSN-2018.1-Eng.Pdf
Printable Version [PDF]
Pharmaceuticals (Monocomponent Products) ………………………..………… 31 Pharmaceuticals (Combination and Group Products) ………………….……
Desk Reference Guide
Practice Parameter: Management of Dementia (An Evidence-Based Review)
ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
'Cerebroactive' Drugs Clinical Pharmacology and Therapeutic Role in Cerebrovascular Disorders
(12) United States Patent (10) Patent No.: US 8,383,152 B2 Jans Et Al
Electronic Supplementary Material (ESI) for Organic & Biomolecular
Top View
Australian Statistics on Medicines 2009
Compositions and Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates
A Small Molecule Drug Screening Identifies Colistin Sulfate As an Enhancer of Natural Killer
PSYCHOACTIVE SUBSTANCES a Guide to Ethnobotanical Plants and Herbs, Synthetic Chemicals, Compounds and Products
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Mesh Terms for 2002
WO 2U11/132171 Al
(12) Patent Application Publication (10) Pub. No.: US 2017/0056347 A1 Glick Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Vincamine Dietary Supplements 1617-90-9
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
Supplemental Material BMJ Open Doi: 10.1136/Bmjopen-2020-039747 :E039747. 10 2020; BMJ Open , Et Al. Müller BS
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
United States Patent 19 11 Patent Number: 5,652,261 Ismail 45 Date of Patent: *Jul
205003Orig1s000
Phosphodiesterase Inhibitors for Alzheimer's Disease
Resolution Ap (2000) 1
ATC Code Title
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving